POSTER Presented at ASM Clinical Virology Symposium 2019
Influenza viruses are responsible for seasonal epidemics each year in the United States that result in an average of 200,000 hospitalizations and tens of thousands of deaths.
Accurate and early diagnosis of influenza viral infections is critical.
Using simple and efficient pre-concentration workflows combined with existing molecular test formats can improve detection at earlier time points.
Nanotrap® particles can improve flu virus detection by pre-concentrating flu virus from viral transport media samples for RT-PCR detection.
Methods are amenable to automation.
Nanotrap® particles preserve pathogens at elevated temperatures.
Incorporating Nanotrap® particles in the transport media could further improve sample processing workflows and downstream assay.